Le, X., Hernandez, M., Heeke, S., Saltos, A., Heymach, J. V. (2025). Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00032